Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; (CSE: $DIXI_U.C)
(OTCQX: $DXBRF) (CSE: $AUSA.C)
(CSE: $BEV.C)
Delta, Kelowna, BC, January 16, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few early announcements.
But
first, The Medical Cannabis Clinics, recently CQC registered, is
the UK's largest and fastest growing chain of private
cannabis clinics, with doctors now operating from seven locations across the
country and more openings planned over the coming months to meet patient
demand.
Through
working in collaboration with the global leaders in medical cannabis education
and training, The Academy of Medical Cannabis, the clinic chain has amassed a
team of skilled clinicians who have been trained to prescribe cannabis-based
medicine.
The
demand for cannabinoid medicine has never been more evident after this week's
release of a YouGov poll suggesting a staggering 1.4 million British citizens
are resorting to using cannabis illegally in an attempt to treat a range of
conditions and symptoms.
According
to Jonathan Nadler, Group MD at LYPHE Group: "Patients should be able to
access legal medical cannabis but both advocates and doctors have been
thoroughly dissatisfied with the lack of progress since cannabis was
rescheduled in 2018. Many were outraged when NICE issued their latest
recommendations a couple of months ago in which only two cannabis-based drugs,
Epidyolex and Sativex, were recommended for use by those suffering from either
rare forms of childhood-onset epilepsy or spasticity related to multiple sclerosis. This
update left many, including patients suffering from other conditions like
fibromyalgia and chronic pain, feeling snubbed by the healthcare institute and
the medical community as a whole. NICE's guidance is often taken as gospel by
healthcare professionals who won't prescribe without its explicit
authorisation."
However
the NICE guidance does not override the responsibility of healthcare
professionals to carefully assess and assign the appropriate line of treatment
in their patients' best interests. So, through asserting the right to their own
clinical discretion around their patient's treatment and care, specialists are
now taking back their power to prescribe, providing high quality and effective
medical cannabis care in the process.
The
guidelines specifically state: 'Once NICE guidance is published, health
professionals are expected to take it fully into account when exercising their
clinical judgement. However, NICE guidance does not override the individual
responsibility of health professionals to make appropriate decisions according
to the circumstances of the individual patient in consultation with the patient
and / or their guardian or carer.'
Jonathan
Nadler added: "Doctors operating with The Medical Cannabis Clinics are not
afraid to exercise their knowledge and expertise to write medical cannabis
prescriptions for patients who need it. With clinics in London (Harley Street),
Birmingham (Solihull), Manchester, Nottingham, Leeds, Newcastle and Bristol, we
are proud to be assisting patients across the country."
Dixie Brands Inc. (CSE:
DIXI.U) (OTCQX:
DXBRF), one of the cannabis industry's leading consumer
packaged goods ("CPG") companies, confirmed that, in conjunction with
its manufacturer, it
will launch Dixie's initial branded product offering into the Oklahoma
medical cannabis market by the end of January 2020, meeting its expectation
announced in the previous press release related to the Oklahoma expansion. The
initial offering will be followed by a full portfolio launch, including Dixie's
pioneering CBD brand AcesoHemp, in February 2020.
Dixie,
a pioneer in the development of infused-cannabis products since 2010, has built
one of the industry's most comprehensive portfolios via a deep R&D and
production heritage built over nearly a decade. With over 100 products across
more than 15 different product categories, the portfolio represents one of the
industry's most extensive 'House of Brands' encompassing both regulated THC and
ratio brands in Dixie and Synergy and hemp-derived CBD offerings, including
AcesoHemp and Therabis.
Oklahoma
is one of the country's fastest growing legal cannabis markets with over
200,000 registered patients driving more than $250 million in regulated retail
sales as of October 2019 (source: KUTL, December 4th, 2019). With more than 5%
of the state's population now registered as medical cannabis patients,
exceeding any other program in the nation, the category was expected to eclipse
$350 million by the end of 2019 (Source: Marijuana Business Daily, November 19,
2019). The passing of SQ788 (the bill legalizing cannabis for medical use)
provides the opportunity for licensed dispensaries to offer patients both THC
and hemp-derived CBD products.
"We
are excited to be bringing Dixie's unparalleled portfolio of THC &
CBD-infused brands to 200,000 medical patients in the dynamic Oklahoma
market" said Chuck Smith, President and CEO, Dixie Brands. "The fact
that we are able to bring product to market within 60 days of announcing our
licensed manufacturing partner is a testament to the agility and expertise the
Dixie Brands team has developed over a decade in business".
The
growth of Oklahoma's medical cannabis market to date has been far greater than
any other medical market launch. 2019 saw medical patient counts increase
eightfold and over 2,000 dispensary licences issued (Source: Marijuana Business
Daily, November 19, 2019), providing an exciting early mover opportunity for
Dixie's well-established portfolio of brands in this rapidly growing market.
Australis Capital
Inc.
(CSE:
AUSA) (OTC:
AUSAF) announced that
AUSA's wholly-owned brands Tsunami™, a science-driven recreational extract
brand, and GT Flowers, continue to receive industry recognition as leaders in
product innovation and quality with wins at the High Times Cannabis Cup Nevada
2019 in a rare four-category sweep: 1st Place Best Indica
Concentrates, 1st Place Best Sativa Concentrates, 2nd
Place Best Hybrid Concentrates, and 3rd Place Vape Cartridges. As
the premier competition in the cannabis industry, the High Times Cannabis Cup
spotlights top companies and products in the Nevada cannabis market.
"The
great showing at the High Times Cup validates the hard work, creativity and
care Green Therapeutics uses when approaching the cultivation and extraction
processes," said Dr. Duke Fu, CEO of Green Therapeutics, LLC. "We are
proud to have been successful in the manufacturing and creation of
differentiated products that bring joy to our customers."
As
the cannabis industry continues expanding, consumers are seeking
premium-quality cannabis options from quality suppliers. Tsunami™, Provisions™,
and GT Flowers answer this demand with high-quality, innovative products, a
wide array of phenotypes, and broad distribution through some of the largest
dispensaries in Nevada, including Planet 13, The Source, and THRIVE
Marketplace. GT Flowers is exclusively sold through The Source and in 2019,
Tsunami™ became the exclusive premium extract provider to the only consumption
lounge in Nevada.
"These
wins along with the growth of AUSA's brands in Nevada prove that marijuana
brands built on quality cultivation, extraction, marketing, and management will
thrive and grow with the consumer," said Cleve Tzung, SVP of Mergers &
Acquisitions at AUSA. "We're very proud of the GT team that was acquired
less than a year ago and look forward to introducing our award-winning brands
to new markets in the coming months."
Tsunami™,
Provisions™, and GT Flowers continue to increase sales, focusing on high
turnover SKUs to supply the high volume demands from some of the largest
dispensaries in Nevada, while expanding and developing new dispensary
partnerships.
BevCanna
Enterprises Inc. (CSE:
BEV)
(OTCQB:BVNNF) announced that it
has acquired Carmanah Craft Corp.
Pursuant
to a share exchange agreement dated January 13, 2020 with Carmanah and each of
the shareholders of Carmanah, the Company has completed the acquisition of all
the issued and outstanding securities of Carmanah and the business of Carmanah.
The
acquisition of the cannabis genetics expert gives BevCanna access to an
extensive library of cannabis genetics, including 50 premium cannabis strains
and over 25 types of cannabis seeds, including six auto flower seed varieties.
There is an excess of 50 strains by clone and 250,000 cannabis seeds ranging
from high THC to high CBD. Additionally, a large portion of the genetics are
outdoor-specific strains that originated in California, which boasts a very
similar climatic zone to our operations in the Okanagan and are expected to
increase yields. The library of genetics includes many of the top mold
resistant, outdoor, high yielding, auto flower seeds, many of which are
anticipated at 2kg+ of yield per plant. With the addition of such a substantial
auto flower library, the harvest times will start much earlier allowing for
much more organized final processing.
"This
deal will dramatically increase our overall cannabis yield projections."
said Joey Bedard-Brunet, Head of Cultivation at BevCanna. "Together with
the recently announced increase in our outdoor cannabis cultivable land to
almost 300 acres, the acquisition of Carmanah's proven outdoor genetics will
allow BevCanna to develop into one of the largest outdoor cannabis cultivators
in Canada." said John Campbell, Chief Strategy Officer at BevCanna.
One World Pharma,
Inc. (OTCQB:
OWPC), a fully
licensed pure-play cannabis and hemp ingredient producer in Colombia, has
been honored by the Assembly of the Department of
Cauca, Colombia for its efforts to invest in, develop and empower the local
population in the region. The award is the highest distinction granted by the
Assembly, and was approved unanimously by the governing body.
One
World Pharma’s mission is to create a leading international cannabis and hemp
ingredient company which leverages the extremely beneficial natural conditions
in equatorial Colombia with the best interests of the indigenous people in
mind. To that end, OWP has put the people of the once troubled State of Cauca
first; hiring, training, and partnering hand-in-hand with them in a shared goal
to capitalize on the unique Colombian cannabis and hemp opportunity.
The
company has already hired a large number of indigenous people and created new
opportunities for them to partner in profitable outcomes. In addition, One
World Pharma has overseen the construction of new roads, running water and
other essential amenities.
“We
are proud to walk-the-walk and not just talk-the-talk,” stated Brian Moore,
President, One World Pharma. “Our
company was and is intent on a business model that lifts others up, changes
their lives for the better, and harnesses that goodwill as the driving force to
become a real agent of change in Colombia and the international cannabis and
hemp marketplace. This award, given by those who know us best, is a testament
to our commitment and to the life-changing impact of our devoted team.”
“This
is more than just an honor from our friends and partners for a new Colombia,”
stated Moore. “It is an affirmation of our pledge to work in partnership with
the people who need it most, and to collaborate in this emerging part of
Colombia to benefit their people.”
“As
we draw ever closer to our first harvests and revenue generating activities, it
is heartening to have our core humanitarian mission acknowledged,” added Moore.
“The people of Cauca are now closer to living the lives every human deserves.”
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About
Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news, research and original financial content. Learn
about investing in stocks and sector trends with our news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
